Early carbohydrate antigen 125 as a mortality predictor in hospitalized patients with coronavirus disease 2019
BackgroundCarbohydrate antigen 125 (CA125) is an indicator of inflammation, immune response, and impaired cardiac function. The aim was to investigate whether CA125 behaves as a biomarker of severity and poor clinical outcomes in hospitalized patients with coronavirus disease 2019 (COVID-19).Methods...
Main Authors: | Oscar Moreno-Perez, Julio Nuñez, Miriam Sandin-Rollan, Vicente Arrarte, Vicente Boix, Sergio Reus, Hector Pinargote-Celorio, Isabel Ribes, Rocio Alfayate, Maria Belen Llorca-Santos, Maria Angeles Martinez-Garcia, Pablo Chico-Sánchez, Esperanza Merino |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.941512/full |
Similar Items
-
A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status
by: José Manuel Ramos-Rincón, et al.
Published: (2023-10-01) -
Hospitalized patients with breakthrough COVID-19: Clinical features and poor outcome predictors
by: Oscar Moreno-Perez, et al.
Published: (2022-05-01) -
Prognostic significance of carbohydrate antigen 125 in stage D heart failure
by: Ji Zhang, et al.
Published: (2023-02-01) -
Carbohydrate Antigen 125 Is a Biomarker of the Severity and Prognosis of Pulmonary Hypertension
by: Yi Zhang, et al.
Published: (2021-07-01) -
Role of neuron specific enolase, carbohydrate antigen 125, and carbohydrate antigen 199 in monitoring the pulmonary fibrosis progression of pneumoconiosis
by: CHEN Yuquan
Published: (2023-12-01)